Abbott's (ABT) growth is backed by strong improvement in global Core Laboratory Diagnostics sales, led by continued strong adoption of the Alinity family of diagnostics systems and testing portfolios. Within the Nutrition business, the company is driving robust growth in Adult Nutrition. However, dull macroeconomic scenarios and currency fluctuations may restrict Abbott's growth potential. In the past year, this Zacks Rank #3 (Hold) company's shares have risen 22.7% compared with the industry's 32.1% growth ...